These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29343519)

  • 1. Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.
    Kolachalama VB; Shashar M; Alousi F; Shivanna S; Rijal K; Belghasem ME; Walker J; Matsuura S; Chang GH; Gibson CM; Dember LM; Francis JM; Ravid K; Chitalia VC
    J Am Soc Nephrol; 2018 Mar; 29(3):1063-1072. PubMed ID: 29343519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.
    Walker JA; Richards S; Whelan SA; Yoo SB; Russell TL; Arinze N; Lotfollahzadeh S; Napoleon MA; Belghasem M; Lee N; Dember LM; Ravid K; Chitalia VC
    J Am Soc Nephrol; 2021 Nov; 32(11):2834-2850. PubMed ID: 34716244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.
    Shivanna S; Kolandaivelu K; Shashar M; Belghasim M; Al-Rabadi L; Balcells M; Zhang A; Weinberg J; Francis J; Pollastri MP; Edelman ER; Sherr DH; Chitalia VC
    J Am Soc Nephrol; 2016 Jan; 27(1):189-201. PubMed ID: 26019318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
    Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
    Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
    Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis.
    Belghasem M; Roth D; Richards S; Napolene MA; Walker J; Yin W; Arinze N; Lyle C; Spencer C; Francis JM; Thompson C; Andry C; Whelan SA; Lee N; Ravid K; Chitalia VC
    Blood; 2019 Dec; 134(26):2399-2413. PubMed ID: 31877217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells.
    Lano G; Laforêt M; Von Kotze C; Perrin J; Addi T; Brunet P; Poitevin S; Burtey S; Dou L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.
    Shashar M; Belghasem ME; Matsuura S; Walker J; Richards S; Alousi F; Rijal K; Kolachalama VB; Balcells M; Odagi M; Nagasawa K; Henderson JM; Gautam A; Rushmore R; Francis J; Kirchhofer D; Kolandaivelu K; Sherr DH; Edelman ER; Ravid K; Chitalia VC
    Sci Transl Med; 2017 Nov; 9(417):. PubMed ID: 29167396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
    Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
    Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.
    Chitalia VC; Shivanna S; Martorell J; Balcells M; Bosch I; Kolandaivelu K; Edelman ER
    Circulation; 2013 Jan; 127(3):365-76. PubMed ID: 23269489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models.
    Karbowska M; Kaminski TW; Marcinczyk N; Misztal T; Rusak T; Smyk L; Pawlak D
    Toxins (Basel); 2017 Jul; 9(7):. PubMed ID: 28753957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.
    Shih YC; Wu CC; Wang SC; Liou JY; Huang PH; Tarng DC
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32276394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor.
    Asai H; Hirata J; Watanabe-Akanuma M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease.
    Thome T; Vugman NA; Stone LE; Wimberly K; Scali ST; Ryan TE
    JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.
    Santana Machado T; Poitevin S; Paul P; McKay N; Jourde-Chiche N; Legris T; Mouly-Bandini A; Dignat-George F; Brunet P; Masereeuw R; Burtey S; Cerini C
    J Am Soc Nephrol; 2018 Mar; 29(3):906-918. PubMed ID: 29222397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.